Monte Rosa Therapeutics
GLUE
GLUE
68 hedge funds and large institutions have $272M invested in Monte Rosa Therapeutics in 2023 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 33 increasing their positions, 10 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
10% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 10
12% less capital invested
Capital invested by funds: $310M → $272M (-$37.5M)
Holders
68
Holding in Top 10
2
Calls
$511K
Puts
–
Top Buyers
| 1 | +$18.1M | |
| 2 | +$2.79M | |
| 3 | +$1.72M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$1.44M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.39M |
Top Sellers
| 1 | -$22.5M | |
| 2 | -$11.7M | |
| 3 | -$912K | |
| 4 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$166K |
| 5 |
Squarepoint
New York
|
-$109K |